One of the drugs they commonly use is called anastrozole. Researchers are looking for ways to improve standard treatments. In this study, they were looking at a drug called AZD8931 together with ...

Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, ...

According to AZ, SERENA-6 is also the first pivotal trial to show the value of measuring circulating tumour DNA (ctDNA) to ...

AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as ... with aromatase inhibitors like anastrozole or letrozole.

According to the National Institute on Drug Abuse (NIDA), continuous use of AASs can lead to problems such as tolerance, meaning a person needs higher doses to achieve the same effects.

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

The supplementation did not have a clear effect on blood sugar levels. Another study found that the same dosage did not significantly impact fasting insulin levels or insulin sensitivity.

BASEL, Switzerland I June 1, 2025 I Novartis is announcing data from a new subgroup analysis of the Phase III NATALEE trial evaluating the efficacy and safety ...